老年孤立性髋部骨折:骨科老年共管与标准治疗的实践管理指南
东部创伤外科协会实践管理指南委员会采用GRADE方法及荟萃分析,系统检索1900年1月1日至2017年8月31日文献,评价≥65岁孤立性髋部骨折患者接受常规骨科老年共管(OG)与不常规OG管理相比能否降低死亡率、改善出院去向、功能结局、减少院内并发症及缩短住院时间。共评估45篇文章,6项随机对照试验和7项回顾性病例对照研究纳入定量分析。回顾性病例对照研究显示OG有30天死亡率获益(OR 0.78 [0.67, 0.90]),但前瞻性研究或1年时未显示;OG组功能结局更优,4个月简易体能状况量表评分改善(MD 0.78 [0.28, 1.29]),12个月简易精神状态检查评分改善(MD 1.57 [0.40, 2.73]),4和12个月两项日常活动能力测试均改善;出院去向无差异;OG组院内获得性压力性损伤更少(OR 0.30 [0.15, 0.60]);其他并发症及住院时间无差异。总体证据质量低,指南有条件推荐OG照护模式。
要点
- 回顾性病例对照研究显示OG组30天死亡率获益(OR 0.78 [0.67, 0.90]),但前瞻性研究或1年时未显示该获益。
- OG组4个月简易体能状况量表评分改善(MD 0.78 [0.28, 1.29]),12个月简易精神状态检查评分改善(MD 1.57 [0.40, 2.73])。
- OG组4和12个月两项日常活动能力测试均改善,出院去向无差异。
- OG组院内获得性压力性损伤更少(OR 0.30 [0.15, 0.60]),其他并发症及住院时间无差异。
- 总体证据质量低,指南有条件推荐对≥65岁孤立性髋部骨折患者采用OG照护模式以改善结局。
适用人群与场景
- ≥65岁孤立性髋部骨折的老年创伤患者。
处置流程与药物剂量
- 对≥65岁孤立性髋部骨折患者,有条件推荐采用骨科老年共管(OG)照护模式以改善患者结局(证据质量低)。
研究设计与关键结果
- 系统评价与荟萃分析:检索1900年1月1日至2017年8月31日文献,评估45篇文章,6项随机对照试验和7项回顾性病例对照研究纳入定量分析。
- 主要结局:回顾性病例对照研究显示OG组30天死亡率获益(OR 0.78 [0.67, 0.90]),但前瞻性研究或1年时未显示。
- 功能结局:OG组4个月简易体能状况量表评分改善(MD 0.78 [0.28, 1.29]),12个月简易精神状态检查评分改善(MD 1.57 [0.40, 2.73]),4和12个月两项日常活动能力测试均改善。
- 出院去向:OG组与对照组无差异。
- 重要结局:OG组院内获得性压力性损伤更少(OR 0.30 [0.15, 0.60]),其他并发症及住院时间无差异。
- 总体证据质量低。
证据类型、等级与局限
- 证据类型:系统评价/荟萃分析,证据等级III级;总体证据质量低。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者有条件推荐对≥65岁孤立性髋部骨折患者采用OG照护模式以改善结局,证据质量低。
- 回顾性病例对照研究显示OG与30天死亡率降低相关,但前瞻性研究或1年时未显示该获益。
- OG与4个月简易体能状况量表评分、12个月简易精神状态检查评分及4和12个月日常活动能力改善相关。
- OG与院内获得性压力性损伤减少相关,其他并发症及住院时间无差异。
指南或共识出处
- 东部创伤外科协会(Eastern Association for the Surgery of Trauma)实践管理指南,发表于J Trauma Acute Care Surg。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Elderly patients commonly suffer isolated hip fractures, causing significant morbidity and mortality. The use of orthogeriatrics (OG) management services, in which geriatric specialists primarily manage or co-manage patients after admission, may improve outcomes. We sought to provide recommendations regarding the role of OG services.
METHODS: Using GRADE methodology with meta-analyses, the Practice Management Guidelines Committee of the Eastern Association for the Surgery of Trauma conducted a systematic review of the literature from January 1, 1900, to August 31, 2017. A single Population, Intervention, Comparator and Outcome (PICO) question was generated with multiple outcomes: Should geriatric trauma patients 65 years or older with isolated hip fracture receive routine OG management, compared with no-routine OG management, to decrease mortality, improve discharge disposition, improve functional outcomes, decrease in-hospital medical complications, and decrease hospital length of stay?
RESULTS: Forty-five articles were evaluated. Six randomized controlled trials and seven retrospective case-control studies met the criteria for quantitative analysis. For critical outcomes, retrospective case-control studies demonstrated a 30-day mortality benefit with OG (OR, 0.78 [0.67, 0.90]), but this was not demonstrated prospectively or at 1 year. Functional outcomes were superior with OG, specifically improved score on the Short Physical Performance Battery at 4 months (mean difference [MD], 0.78 [0.28, 1.29]), and improved score on the Mini Mental Status Examination with OG at 12 months (MD, 1.57 [0.40, 2.73]). Execution of activities of daily living was improved with OG as measured by two separate tests at 4 and 12 months. There was no difference in discharge disposition. Among important outcomes, the OG group had fewer hospital-acquired pressure ulcers (OR, 0.30 [0.15, 0.60]). There was no difference in other complications or length of stay. Overall quality of evidence was low.
CONCLUSION: In geriatric patients with isolated hip fracture, we conditionally recommend an OG care model to improve patient outcomes.
LEVEL OF EVIDENCE: Systematic review/meta-analysis, level III.
参考来源
- Mukherjee K, Brooks SE, Barraco RD, et al. Elderly adults with isolated hip fractures- orthogeriatric care versus standard care: A practice management guideline from the Eastern Association for the Surgery of Trauma. J Trauma Acute Care Surg. 2020. PMID: 31464870. doi:10.1097/TA.0000000000002482
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。